SAN CARLOS, Calif., April 14, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported it has entered into an agreement for litigation financing which has been filed today with the Securities and Exchange Commission on Form 8-K. BioCardia, Inc. […]
Other News
Cytokinetics Provides Clinical Trials and Business Update in Response to COVID-19 Pandemic
Top-line Results for GALACTIC-HF Expected in Q4 2020; Enrollment in METEORIC-HF Temporarily Suspended SOUTH SAN FRANCISCO, Calif., April 14, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today provided an update regarding the company’s clinical trials and business operations related to its response to the COVID-19 pandemic alongside its commitment to […]
Johnson & Johnson Reports 2020 First-Quarter Results
– Sales of $20.7 billion reflecting strong growth of 3.3%, operational growth of 4.8%* and adjusted operational growth of 5.6%*, inclusive of the overall estimated negative impact of the COVID-19 pandemic – EPS of $2.17 increased 56.1%; adjusted EPS of $ 2.30 increased 9.5%* – Dividend increase of 6.3% announced […]
DiNovA Medtech Announces Vivek Y. Reddy, MD to Join as Portfolio Company’s Medical Advisor and Cofounder
HANGZHOU, China, April 14, 2020 /PRNewswire/ — DiNovA Medtech, the leading medical devices incubator in China (“DiNovA”, or the “Company”), is pleased to announce Vivek Y. Reddy, MD to join as Chief Medical Advisor and Cofounder of portfolio company Nuomao Medtech (“Nuomao”) to lead cardiac arrhythmia related innovations. Vivek Y. Reddy, MD is the Director […]
Italian Vascular Access Group Recommends Use of SecurAcath on COVID-19 Patients
PLYMOUTH, Minn.–(BUSINESS WIRE)–Interrad Medical, a privately held medical device company, announces a new recommendation for use of SecurAcath on COVID-19 patients. The recommendation document was released on April 5, 2020 by a group of experts from the Long Term Central Venous Access Group (GAVeCeLT) and covers important aspects of vascular […]
Bluegrass Vascular Technologies Welcomes National Kidney Foundation’s Revamp of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Vascular Access
Updated 2019 guidelines emphasize vessel preservation, aligns with the Surfacer® System’s “Don’t Go Left™” approach SAN ANTONIO, April 14, 2020 /PRNewswire/ — Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, welcomes the recent publication of the 2019 Update to […]
AtriCure Announces CONVERGE IDE Trial Results Accepted for Late-Breaking Clinical Trial Sessions at Annual Heart Rhythm Society (HRS) Meeting
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that results from the CONVERGE IDE trial have been accepted for presentation in the late-breaking abstract sessions at the Heart Rhythm Society (HRS) Scientific Sessions. The abstract will […]
Blackstone and Alnylam Enter Into $2 Billion Strategic Financing Collaboration to Accelerate the Advancement of RNAi Therapeutics
– RNAi Represents One of the Most Promising and Rapidly Advancing Frontiers in Biology and Drug Development Today with Potential to Transform Lives of Patients – – Blackstone Provides a Customized Investment at Scale to Enable Alnylam to Achieve Self-sustainable Financial Profile Without Need for Future Equity Financing – – […]
Shockwave Completes Enrollment of Coronary Intravascular Lithotripsy Study in Japan
DISRUPT CAD IV Clinical Study to Support Regulatory Device Approval in Japan SANTA CLARA, Calif., April 13, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the company has completed enrollment in […]
Itamar™ Medical Announces First Quarter 2020 Preliminary Revenue Increase of Approximately 40%
– Company Ramping Up WatchPAT™ ONE Production Capacity to Meet Demand for Disposable Home Sleep Apnea Tests – CAESAREA, Israel, April 13, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices, solutions and a […]
Recent
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress
Novo Nordisk global observational study reveals 2 in 5 people with cardiovascular disease have cardiovascular inflammation, increasing their risk of heart attack and stroke
Popular
- No commented posts yet